Precision Biosciences Inc financial data

Symbol
DTIL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
302 East Pettigrew Street, Suite A 100, Durham, North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 310 % -18.2%
Debt-to-equity 479 % +90.9%
Return On Equity -92.9 % +38.4%
Return On Assets -16 % +62.7%
Operating Margin -60.1 % +62%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.92 M shares -93.8%
Common Stock, Shares, Outstanding 6.92 M shares -93.8%
Entity Public Float 59.1 M USD -65.3%
Common Stock, Value, Issued 1 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.06 M shares +36.4%
Weighted Average Number of Shares Outstanding, Diluted 5.06 M shares +36.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 57.5 M USD +88.3%
Research and Development Expense 55.7 M USD +49.7%
General and Administrative Expense 36.4 M USD -12.6%
Operating Income (Loss) -34.6 M USD +28.5%
Net Income (Loss) Attributable to Parent -27.7 M USD +74.5%
Earnings Per Share, Basic -7.51 USD/shares +83.1%
Earnings Per Share, Diluted -7.51 USD/shares +83.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 138 M USD -12.9%
Accounts Receivable, after Allowance for Credit Loss, Current 390 K USD -43.8%
Other Assets, Current 128 K USD -92.8%
Assets, Current 161 M USD -4.85%
Deferred Income Tax Assets, Net 3.28 M USD +181%
Property, Plant and Equipment, Net 5.29 M USD -71.6%
Operating Lease, Right-of-Use Asset 7.98 M USD +201%
Intangible Assets, Net (Excluding Goodwill) 386 K USD -74.7%
Other Assets, Noncurrent 238 K USD -91.4%
Assets 185 M USD -9.66%
Accounts Payable, Current 1.14 M USD +62.1%
Employee-related Liabilities, Current 1.22 M USD -37.6%
Contract with Customer, Liability, Current 2.41 M USD -93.7%
Liabilities, Current 33.3 M USD -28.9%
Contract with Customer, Liability, Noncurrent 74.8 M USD -9.66%
Deferred Income Tax Liabilities, Net 3.28 M USD +181%
Operating Lease, Liability, Noncurrent 7.41 M USD +232%
Other Liabilities, Noncurrent 766 K USD +253%
Liabilities 148 M USD -10.2%
Retained Earnings (Accumulated Deficit) -481 M USD -6.1%
Stockholders' Equity Attributable to Parent 37.2 M USD -7.4%
Liabilities and Equity 185 M USD -9.66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19 M USD +39.7%
Net Cash Provided by (Used in) Financing Activities 40.1 M USD +5311%
Net Cash Provided by (Used in) Investing Activities -26 K USD +96.4%
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 6.94 M shares -93.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.1 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 138 M USD -12.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 526 K USD +13.4%
Deferred Tax Assets, Valuation Allowance 139 M USD +14.6%
Operating Lease, Liability 8.59 M USD +98.6%
Lessee, Operating Lease, Liability, to be Paid 10.9 M USD +127%
Property, Plant and Equipment, Gross 31.8 M USD -5.52%
Operating Lease, Liability, Current 1.18 M USD -43.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.02 M USD +282%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.96 M USD +23.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +26%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.3 M USD +396%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.08 M USD +281%
Deferred Tax Assets, Operating Loss Carryforwards 45.5 M USD +24.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.14 M USD +475%
Operating Lease, Payments 462 K USD -19.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 12.9 M USD -32%
Interest Expense 2.28 M USD +43.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%